about
Macrophages in multiple myeloma: emerging concepts and therapeutic implications.Hidden among the crowd: differential DNA methylation-expression correlations in cancer occur at important oncogenic pathwaysSynergy of anti-CD40, CpG and MPL in activation of mouse macrophagesTumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple MyelomaCD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunitiesDeploying myeloid cells against myelomaCD40 therapy and surgery: a potential immunologic partnership.Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma model.The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.Monocyte/Macrophage: NK Cell Cooperation-Old Tools for New Functions.A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation.Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro.Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.The Use of Anti-CD40 mAb in Cancer.
P2860
Q34329242-6B5A8142-A23E-49EC-B9D7-611AC2127A21Q35600057-83A77D1C-AD98-4E41-9DC8-DEBC8E14E4BBQ35706554-5E5AD585-1813-47F2-A3FD-9B5ADD8AD0E0Q35925252-2A086D78-EA42-4135-B38F-CDD68DF15391Q36022324-B617A316-2282-45E0-BFA6-0C27B7C175CDQ36447553-18731F82-9784-4A6B-B125-15F4BFCC055FQ36821049-21A806BE-BFA6-4758-8AA8-86CB4FA7254CQ37226420-DCB771D8-6B3A-4A22-933F-36A8945F26B1Q37416204-182669F2-0C45-4C63-A154-0254386425C9Q38073762-CB1DF7DA-F169-42D6-84ED-9846009818C0Q38219409-97C90146-3F42-4485-8319-9BE614D21423Q38941655-B37EE421-0D84-4772-8F63-B6ECE8AAA6ECQ39271596-00ECF7A9-FF15-4D33-BDBE-B8F0C9533F90Q41141811-298868F6-8037-488C-BDC3-7D3C8FA5992DQ43428464-D08DF7A1-343B-48B1-8CBA-F296855CC787Q48375822-E9597494-7BA3-4C81-9408-2738AF2B69EAQ50045161-3FC86FDC-D217-416C-835F-82A222BF8D1DQ53321210-60C2AC90-08A3-4214-BAB8-8CE21A1DE8A9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
T-cell-independent antitumor effects of CD40 ligation.
@en
type
label
T-cell-independent antitumor effects of CD40 ligation.
@en
prefLabel
T-cell-independent antitumor effects of CD40 ligation.
@en
P2093
P2860
P1476
T-cell-independent antitumor effects of CD40 ligation.
@en
P2093
Alexander L Rakhmilevich
Kory L Alderson
Paul M Sondel
P2860
P304
P356
10.3109/08830185.2012.698337
P577
2012-08-01T00:00:00Z